Yulia A. Dagil

Moscow, MOW 115522, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Immunogenic Properties and Safety of a Quadrivalent Inactivated Subunit Adjuvanted Influenza Vaccine in Adults Aged 18 to 85 Years at the End of the COVID-19 Pandemic in the 2022-2023 Season.

Immunogenic Properties and Safety of a Quadrivalent Inactivated Subunit Adjuvanted Influenza Vaccine in Adults Aged 18 to 85 Years at the End of the COVID-19 Pandemic in the 2022-2023 Season.

Journal: Vaccines

Published: January 03, 2026

Immunogenicity of one dose and two doses of adjuvanted influenza vaccine in lung transplant candidates.

Immunogenicity of one dose and two doses of adjuvanted influenza vaccine in lung transplant candidates.

Journal: PloS one

Published: May 03, 2025

Immunoadjuvanted influenza vaccine immunogenicity in children with type 1 diabetes over two consecutive seasons.

Immunoadjuvanted influenza vaccine immunogenicity in children with type 1 diabetes over two consecutive seasons.

Journal: Frontiers in immunology

Published: March 21, 2025

Anti-Inflammatory and Antifibrotic Potential of Longidaze in Bleomycin-Induced Pulmonary Fibrosis.

Anti-Inflammatory and Antifibrotic Potential of Longidaze in Bleomycin-Induced Pulmonary Fibrosis.

Journal: Life (Basel, Switzerland)

Published: July 18, 2023

Protein kinase C isoforms mediate the formation of neutrophil extracellular traps.

Protein kinase C isoforms mediate the formation of neutrophil extracellular traps.

Journal: International immunopharmacology

Published: August 17, 2022

Cellular stress promotes NOD1/2-dependent inflammation via the endogenous metabolite sphingosine-1-phosphate.

Cellular stress promotes NOD1/2-dependent inflammation via the endogenous metabolite sphingosine-1-phosphate.

Journal: The EMBO journal

Published: July 17, 2020

Immunogenicity and Safety of the Quadrivalent Adjuvant Subunit Influenza Vaccine in Seropositive and Seronegative Healthy People and Patients with Common Variable Immunodeficiency.

Immunogenicity and Safety of the Quadrivalent Adjuvant Subunit Influenza Vaccine in Seropositive and Seronegative Healthy People and Patients with Common Variable Immunodeficiency.

Journal: Vaccines

Published: June 26, 2020

Interplay between NOD1 and TLR4 Receptors in Macrophages: Nonsynergistic Activation of Signaling Pathways Results in Synergistic Induction of Proinflammatory Gene Expression.

Interplay between NOD1 and TLR4 Receptors in Macrophages: Nonsynergistic Activation of Signaling Pathways Results in Synergistic Induction of Proinflammatory Gene Expression.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: June 09, 2020

Assessment of Immunogenicity of Adjuvanted Quadrivalent Inactivated Influenza Vaccine in Healthy People and Patients With Common Variable Immune Deficiency.

Assessment of Immunogenicity of Adjuvanted Quadrivalent Inactivated Influenza Vaccine in Healthy People and Patients With Common Variable Immune Deficiency.

Journal: Frontiers in immunology

Published: April 23, 2020

The influence of glatiramer acetate on Th17-immune response in multiple sclerosis.

The influence of glatiramer acetate on Th17-immune response in multiple sclerosis.

Journal: PloS one

Published: February 07, 2020

Glycolytic reprogramming of macrophages activated by NOD1 and TLR4 agonists: No association with proinflammatory cytokine production in normoxia.

Glycolytic reprogramming of macrophages activated by NOD1 and TLR4 agonists: No association with proinflammatory cytokine production in normoxia.

Journal: The Journal of biological chemistry

Published: August 09, 2019

A cell-based test system for the assessment of pharmacokinetics of NOD1 and NOD2 receptor agonists.

A cell-based test system for the assessment of pharmacokinetics of NOD1 and NOD2 receptor agonists.

Journal: International immunopharmacology

Published: May 16, 2018

Showing 1-12 of 15

Last Updated: 09/26/2026